Indoco receives Certificate of EU GMP Compliance from the European Health Authorities for its sterile drug product manufacturing facility, Goa Plant II

Indoco Remedies Limited announced that the Company has received Certificate for EU Good Manufacturing Practices (GMP) Compliance from the European Health Authorities for its sterile drug product manufacturing facility, Goa Plant II located at L32, 33 and 34, Verna Industrial Estate, South Goa-403722.

The EU GMP certification issued by the European Health Authorities confirms that the site complies with the Good Manufacturing Practice requirements.

Commenting on the development, Ms. Aditi Panandikar, Managing Director, Indoco Remedies Ltd.said, "This GMP certification for our sterile drug product manufacturing facility, Goa Plant II is a testament to our relentless efforts to supply quality and affordable medicines across geographies. We remain fully committed to adhering to cGMP standards and consistently delivering quality products to customers and patients worldwide."

Shares of Indoco Remedies Limited was last trading in BSE at Rs. 316.70 as compared to the previous close of Rs. 321.95. The total number of shares traded during the day was 7771 in over 439 trades.

The stock hit an intraday high of Rs. 324.00 and intraday low of 310.05. The net turnover during the day was Rs. 2433994.00.

Source : Equity Bulls

Keywords

IndocoRemedies INE873D01024 Pharmaceuticals EUGMP Certificate Goa Plant2